Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
<p><strong>Aims:</strong><br /> To compare the benefits and harms of naltrexone–bupropion using evidence from clinical study reports.</p><br /> <p><strong>Methods:</strong><br /> We searched Food and Drug Administration and European Medici...
| Autori principali: | , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
Wiley
2020
|